Protective VEGF Inhibition for Isotoxic Dose Escalation in Glioblastoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

146

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

April 10, 2027

Study Completion Date

July 10, 2027

Conditions

Glioblastoma

Interventions

RADIATION

Dose escalation of radiation dose beyond the therapeutic standard

Dose escalation to 75 Gy with concomitant radioprotectant bevacizumab

Trial Locations (1)

RECRUITING

Department of Radiation Oncology, Munich

All Listed Sponsors

lead

Ludwig-Maximilians - University of Munich

OTHER